Sigma Ups Guidance on Rapid Antigen Test Demand
Pharmaceutical wholesaler Sigma Healthcare told the ASX on Wednesday that demand for Rapid Antigen Tests would push underlying earnings up 10% to 15% compared with last year.
Read MorePharmaceutical wholesaler Sigma Healthcare told the ASX on Wednesday that demand for Rapid Antigen Tests would push underlying earnings up 10% to 15% compared with last year.
Read MoreAustralian consumers spent heavily coming out of the Covid Delta lockdowns in the last quarter of 2021 and dragged the economy to a very solid 4.2% rise in annual GDP for 2021.
Read MoreA week after revealing a big rise in earnings, Lynas Rare Earths has surprised with what looks a significant upgrade to the company’s key Mount Weld deposit in WA.
Read MoreCommodity prices surged Tuesday despite a big slide on equity markets as the Russian invasion of Ukraine deepened with indiscriminate missile attacks and troops at the outskirts of the country’s capital Kyiv.
Read MoreExplosives and chemicals group Orica is sticking with the upbeat (though non-specific) outlook for its 2021-22 financial year ahead of the ending of its first half on March 31.
Read MoreFinancial regulator AUSTRAC has launched court action against Crown Resorts, claiming the casino giant breached anti-money laundering law “innumerable” times over the past six years.
Read MoreANZ and CBA were both in the news on Tuesday as the former made some key personnel moves and the latter offloaded an asset, raising expectations for further capital management programs.
Read MoreThe RBA kept monetary policy unchanged at its March meeting on Tuesday, with the cash rate remaining fixed at 0.1%, but is keeping a close eye on the Ukraine crisis for potential economic fallout.
Read MoreThe CBA will raise expectations among investors for another buyback later this year after revealing Tuesday that it had sold part of its stake in a Chinese bank for $A1.8 billion.
Read MoreA weak interim result Monday from Noumi Ltd (the old Freedom Foods) on the final day of the reporting season that was dominated by a mass of negatives, including a slumping share price.
Read MoreZipCo is seeking to buy rival Sezzle in a $491 million all share deal that Zip claims will accelerate its path to profitability, even in the face of tougher conditions in the once buoyant sector.
Read MoreThe battle for IVF operator Virtus continues, with Australian private equity group BGH upping its offer price to $7.65 per share as it goes head-to-head with London based rival CapVest.
Read MoreAllkem released a bullish first set of results since being formed by the merger of Galaxy Resources and Orocobre last August, and it’s clear the lithium price boom is starting to pay off for producers.
Read MoreRetail sales bounced in January, rising 1.8% in seasonally adjusted terms, but that still left them well adrift of December’s huge 4.4% slump.
Read MoreOil major BP has pulled the plug on one of the west’s biggest Russian investments at a cost of up to $A35 billion, becoming the first major western company to cut ties with Russia.
Read MoreA hectic week ahead for the Australian economy with the RBA policy meeting tomorrow and the latest economic growth data the day after, along with the usual raft of monthly figures over the remainder.
Read MoreWarren Buffett is again trying to reassure shareholders and the wider markets that he retains a strong appetite for acquisitions and equity investments, even if he does see his own company as the best of them.
Read MoreThe Australian stockmarket looks like continuing on from Friday’s positive move when trading resumes this morning after Wall Street rebounded sharply, taking ASX 200 futures higher with it.
Read MoreAs if the markets weren’t uncertain and volatile enough already, the Ukrainian Crisis has raised a whole new set of questions needing to be asked and answered about what happens now.
Read MoreChinese sales of what they call New Energy Vehicles (or NEVs) fell in January from December’s record as the first impact of the 30% cut in subsidies for buyers hit home.
Read MoreNewmont has overcome plenty of obstacles – Covid, wet weather in Western Australia, recalcitrant new technology (also in WA) and a slide in production – to post record 2021 earnings.
Read MoreWith Covid restrictions easing, economies re-opening and consumers moving about, the boom sectors like streaming video have become less attractive to more and more investors.
Read MoreThe circumstantial siege that has beset the travel sector since Covid emerged in 2020 shows no signs of letup, just as it seemed some light was breaking through at the end of the tunnel.
Read MoreTPG has lifted its final dividend after its full-year profit jumped 52% as the full impact of the Vodafone takeover kicked in and signs emerged of a recovery in Australia’s mobile market.
Read MoreBigger issues dominated the investment mindset on Thursday as the market took a big dive, rendering virtually moot the reactions to earnings reports from Bega and Blackmores.
Read MoreLike so many companies this reporting season, private hospital operator Ramsay Health Care continued to battle Covid’s impact on staff, materials and business generally in the December half.
Read MoreAnother big loss for Qantas in the six months to December as the company’s plans for a return to normal business in the half were again disrupted by Covid.
Read MoreHigher costs – especially at its core supermarkets business – hit Woolworths in the half year to December as Covid, labour shortages and supply chain problems impacted its operations.
Read MoreWednesday was a typically busy day on the ASX, and here’s the latest news from property heavyweights Scentre Group and Stockland, along with logistics software company WiseTech.
Read MoreLong-time Pilbara Minerals CEO Ken Brinsden has revealed plans to step down by the end of this year, but will get the chance to deliver the company’s first full year result before he goes.
Read MoreA host of records for Aussie mining giant Rio Tinto in its 2021 financial year results: record dividends, record annual revenue, record underlying earnings, and record after-tax profit.
Read MoreCochlear has warned investors it expects the continuing restrictions on elective surgeries here and offshore will see slower growth in hearing implant sales for the year to June.
Read MoreMixed results yesterday from three retailers or suppliers to the sector – Coles, Best and Less, and Costa Group – but all saw their shares rise, going against the broader market selloff.
Read MoreDecember half year earnings for engineering contractor Monadelphous rose more than 17% despite increased margins pressure from continuing labour shortages in the WA resource sector.
Read MoreThe market saw something it didn’t like in Seven Group’s half-yearly earnings report on Tuesday, marking its shares down 7% at one stage despite the numbers looking rock solid.
Read MoreA new CEO usually means a new broom and ideas and a bit of a clean out after a company’s long-time chief moves elsewhere, and so it was for Lendlease in the six months to December.
Read MoreAs we have seen with other resource stocks, last year turned out to be the best in decades thanks to a sustained commodity price boom. Copper/gold miner OZ Minerals didn’t miss out on the fun.
Read MorePandemic-related damage popped up in a couple of interims from retail groups on Monday, while Sonic Healthcare’s good run may just be petering out and A2 Milk’s luck about to turn.
Read More2021’s global steel boom powered Australian/US producer and exporter, BlueScope Steel to its best ever six months and the company says it is expecting this trend to continue into 2022.
Read MoreDespite the AGL board’s advice to the contrary, Monday’s market reaction reckons a deal will be done for the company at around $8 a share and that it will be done soon.
Read More